Get a glimpse into our company and investor data—powered by the PitchBook Platform
$7.27SHARE PRICE(As of Friday Closing)
Iterum Therapeutics PLC is a clinical-stage pharmaceutical company. The company is engaged in developing and commercializing sulopenem to be the first and only oral and intravenous branded penem available globally. The company's sulopenem program has the potential to offer a solution to the problem of antibiotic resistance and the toxicity limitations of existing agents.